These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Association between maternal single nucleotide polymorphisms in genes regulating glucose metabolism and risk for neural tube defects in offspring. Fu Y; Wang LL; Yi D; Jin L; Liu J; Zhang Y; Ren A Birth Defects Res A Clin Mol Teratol; 2015 Jun; 103(6):471-8. PubMed ID: 25369983 [TBL] [Abstract][Full Text] [Related]
44. The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Jensen LE; Hoess K; Whitehead AS; Mitchell LE Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):512-6. PubMed ID: 15959877 [TBL] [Abstract][Full Text] [Related]
45. Genes encoding catalytic subunits of protein kinase A and risk of spina bifida. Zhu H; Lu W; Laurent C; Shaw GM; Lammer EJ; Finnell RH Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):591-6. PubMed ID: 16080189 [TBL] [Abstract][Full Text] [Related]
46. Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease. Infante J; García-Gorostiaga I; Sánchez-Juan P; Sierra M; Martín-Gurpegui JL; Terrazas J; Mateo I; Rodríguez-Rodríguez E; Berciano J; Combarros O Eur J Neurol; 2010 May; 17(5):760-2. PubMed ID: 20039940 [TBL] [Abstract][Full Text] [Related]
47. The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors. Funk M; Endler G; Schillinger M; Mustafa S; Hsieh K; Exner M; Lalouschek W; Mannhalter C; Wagner O Thromb Res; 2004; 113(3-4):217-23. PubMed ID: 15140586 [TBL] [Abstract][Full Text] [Related]
48. The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida. van der Linden IJ; den Heijer M; Afman LA; Gellekink H; Vermeulen SH; Kluijtmans LA; Blom HJ J Mol Med (Berl); 2006 Dec; 84(12):1047-54. PubMed ID: 17024475 [TBL] [Abstract][Full Text] [Related]
49. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan. Wu MM; Chiou HY; Chen CL; Wang YH; Hsieh YC; Lien LM; Lee TC; Chen CJ Toxicol Appl Pharmacol; 2010 Nov; 248(3):226-33. PubMed ID: 20708634 [TBL] [Abstract][Full Text] [Related]
50. Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma. Tang D; Tang WJ; Shi XL; Li WP; Zhou H; Lu LM; Tao L Acta Otolaryngol; 2016 Aug; 136(8):806-11. PubMed ID: 27400252 [TBL] [Abstract][Full Text] [Related]
52. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c --> t methylenetetrahydrofolate reductase and 2756a --> g methionine synthase genotypes. Lucock M; Daskalakis I; Briggs D; Yates Z; Levene M Mol Genet Metab; 2000 May; 70(1):27-44. PubMed ID: 10833329 [TBL] [Abstract][Full Text] [Related]
53. A known functional polymorphism (Ile120Val) of the human PCMT1 gene and risk of spina bifida. Zhu H; Yang W; Lu W; Zhang J; Shaw GM; Lammer EJ; Finnell RH Mol Genet Metab; 2006 Jan; 87(1):66-70. PubMed ID: 16256389 [TBL] [Abstract][Full Text] [Related]
54. Association between the (GT)n polymorphism of the HO-1 gene promoter region and cancer risk: a meta-analysis. Zhang L; Song FF; Huang YB; Zheng H; Song FJ; Chen KX Asian Pac J Cancer Prev; 2014; 15(11):4617-22. PubMed ID: 24969894 [TBL] [Abstract][Full Text] [Related]
55. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. Song F; Li X; Zhang M; Yao P; Yang N; Sun X; Hu FB; Liu L Am J Epidemiol; 2009 Sep; 170(6):747-56. PubMed ID: 19696228 [TBL] [Abstract][Full Text] [Related]
56. An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Franke B; Vermeulen SH; Steegers-Theunissen RP; Coenen MJ; Schijvenaars MM; Scheffer H; den Heijer M; Blom HJ Birth Defects Res A Clin Mol Teratol; 2009 Mar; 85(3):216-26. PubMed ID: 19161160 [TBL] [Abstract][Full Text] [Related]
57. Genotype and allele frequencies of heme oxygenase-1 promoter region in a Greek cohort. Katana EP; Skoura LG; Scouras ZG; Daniilidis MA Chin Med J (Engl); 2011 Oct; 124(20):3408-11. PubMed ID: 22088544 [TBL] [Abstract][Full Text] [Related]
58. Microsatellite polymorphism in the heme oxygenase-1 gene promoter and the risk of atrial fibrillation in Taiwanese. Hsu LA; Yeh YH; Kuo CT; Chen YH; Chang GJ; Tsai FC; Chen WJ PLoS One; 2014; 9(9):e108773. PubMed ID: 25268359 [TBL] [Abstract][Full Text] [Related]
59. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Volcik KA; Shaw GM; Zhu H; Lammer EJ; Laurent C; Finnell RH Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):924-8. PubMed ID: 14745930 [TBL] [Abstract][Full Text] [Related]
60. Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients. Funke C; Tomiuk J; Riess O; Berg D; Soehn AS J Neural Transm (Vienna); 2009 Jul; 116(7):853-9. PubMed ID: 19475336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]